Insider Holders & Insider Ownership - ACCELERON PHARMA INC (XLRN)

List of insiders holdings for ACCELERON PHARMA INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
CELGENE CORP
BRISTOL MYERS SQUIBB CO
10% Owner
2020-07-16 17:01:157,008,510
0
7,008,510Form 13D
ATV Entrepreneurs VII L.P.
10% Owner
2013-09-19 12:09:582,662,092
0
2,662,092Form 3
GORDON CARL L
Director
2013-09-18 21:25:520
2,272,819
2,272,819Form 3
Advanced Technology Ventures VI L.P.
Advanced Technology Ventures VII(B) L.P.
Advanced Technology Ventures VII(C) L.P.
ADVANCED TECHNOLOGY VENTURES VII LP
ATV Alliance 2003 L.P.
ATV Associates VI L.L.C.
ATV Associates VII L.L.C.
ATV Entrepreneurs VI L.P.
10% Owner
2016-02-16 10:41:531,677,399
0
1,677,399Form 13G
VENROCK ASSOCIATES IV L P
Venrock Partners L.P.
VENROCK ENTREPRENEURS FUND IV L P
Venrock Management IV LLC
Venrock Partners Management LLC
VEF Management IV LLC
10% Owner
2015-02-13 16:41:411,494,440
0
1,494,440Form 13G
MCGUIRE TERRANCE
Polaris Venture Management Co IV LLC
POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP
POLARIS VENTURE PARTNERS IV LP
Director
2015-08-26 20:21:591,492,055
0
1,492,055Form 13D
Knopf John L
CEO and President
2016-11-14 17:49:46403,717
0
403,717Form 4
Ertel Steven D
EVP & Chief Operating Officer
2017-03-14 18:15:09184,277
0
184,277Form 4
Maniatis Tom
Director
2019-01-29 17:47:06144,231
0
144,231Form 4
Steininger Robert J II
SVP, Manufacturing
2013-09-18 21:27:34125,000
0
125,000Form 3
Kumar Ravindra
SVP & Chief Scientific Officer
2019-09-10 20:24:4586,986
0
86,986Form 4
Sherman Matthew L
EVP & Chief Medical Officer
2018-04-04 16:39:0968,767
8,500
77,267Form 4
Quisel John D
EVP, Chief Business Officer
2020-01-03 21:45:0953,316
0
53,316Form 4
POPS RICHARD F
Director
2019-01-29 17:48:3940,000
0
40,000Form 4
Zeldin Robert K
EVP & Chief Medical Officer
2019-01-29 17:40:1532,103
0
32,103Form 4
Rovaldi Christopher
SVP, Program Mgmt and Ops
2018-04-04 16:41:1325,858
0
25,858Form 4
EVNIN ANTHONY B
Director
2013-12-09 17:19:4420,000
0
20,000Form 4
George Jean
Director
2020-01-24 17:41:3313,312
0
13,312Form 4
KANIA EDWIN M JR
Director
2015-04-08 17:05:4110,000
0
10,000Form 4/A
MCGUIRE TERRANCE
Director
2017-03-14 18:22:588,750
0
8,750Form 4
Zakrzewski Joseph S
Director
2021-11-22 09:12:320
0
0Form 4
Malik Kemal
Director
2021-11-22 09:11:360
0
0Form 4
Hite Christopher
Director
2021-11-22 09:10:420
0
0Form 4
Smith Karen L.
Director
2021-11-22 09:09:560
0
0Form 4
MCCOURT Thomas A
Director
2021-11-22 09:08:560
0
0Form 4
Kearney Terrence C
Director
2021-11-22 09:08:110
0
0Form 4
Hamill Laura
Director
2021-11-22 09:07:240
0
0Form 4
Nader Francois
Director
2021-11-22 09:06:360
0
0Form 4
Veness Adam M
SVP, General Counsel and Sec.
2021-11-22 09:05:460
0
0Form 4
KANGO SUJAY
EVP, Chief Commercial Officer
2021-11-22 09:04:550
0
0Form 4
Backstrom Jay T.
EVP, Research and Development
2021-11-22 09:04:070
0
0Form 4
MCLAUGHLIN KEVIN F
SVP, CFO and Treasurer
2021-11-22 09:03:190
0
0Form 4
Dable Habib J
CEO and President
2021-11-22 09:02:280
0
0Form 4
AGTC ADVISORS FUND LP
Applied Genomic Technology Capital Fund LP
AGTC Partners L.P.
AFEYAN NOUBAR
NewcoGen Group Inc.
Flagship Ventures Management Inc.
KANIA EDWIN M JR
10% Owner
2015-02-12 17:26:590
0
0Form 13G
ORBIMED ADVISORS LLC
ORBIMED CAPITAL GP II LLC
ISALY SAMUEL D
Former 10% Owner
2015-02-17 16:17:390
0
0Form 13G
Golumbeski George
Director
2013-09-18 21:21:420
0
0Form 3